Top compounds associated with response to C1orf216


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib GDSC1000 pan-cancer AAC 0.19 3e-07
mRNA TL-2-105 GDSC1000 pan-cancer AAC 0.16 2e-06
mRNA masitinib GDSC1000 pan-cancer AAC 0.15 2e-05
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 3e-05
mRNA ML239 CTRPv2 pan-cancer AAC 0.17 4e-05
mRNA lapatinib CCLE pan-cancer AAC -0.19 9e-05
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA niclosamide CTRPv2 pan-cancer AAC 0.16 0.0001
mRNA BRD-K30748066 CTRPv2 pan-cancer AAC 0.48 0.0001
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.15 0.0002
Download CSV